ENTITY
Yichang HEC Changjiang Pharma

Yichang HEC Changjiang Pharma (1558 HK)

53
Analysis
Health CareHong Kong
YiChang HEC ChangJiang Pharmaceutical Co Ltd develops a variety of drugs. The Company develops and sells drugs for anti-virus, metabolic diseases, cardiovascular, and more.
more
Refresh
bullishESR Group
18 May 2024 15:00

(Mostly) Asia-Pac M&A: ESR Group, I'Rom Group, S Line, Huafa Property Services, Kansai Super Market

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

Logo
347 Views
Share
04 Jan 2024 09:30

HEC Pharma (1558 HK): Strong Performance to Continue as Flu Activity Is On Rise In China

HEC Pharma should benefit from the upsurge in respiratory illness in China. With a forward P/E of 4.8x and 14% YoY EPS growth expectation for 2024,...

Logo
620 Views
Share
02 Oct 2023 21:57

HEC Pharma (1558 HK): Robust 1H23 Performance on Flu Outbreak in China

HEC Pharma reports impressive revenue growth of 148% YoY in 1H23, driven by strong sales of Kewei for influenza treatment. The company obtained...

Logo
428 Views
Share
13 May 2024 04:35

Merger Arb Mondays (13 May) - GA Pack, HEC Pharma, L'Occitane, Alps Logistics, Great Eastern

This week, the highest gross spreads are HEC Pharma (58.1%), Alps Logistics (14.3%), Hollysys (12.9%), Ansarada (8.7%), Southern Cross (8.7%), QV...

Logo
289 Views
Share
12 May 2024 03:53

Weekly Deals Digest (12 May) - China TCM, GA Pack, HEC CJ Pharma, CPMC, Alps Logistics, Infocom

Last week, notable developments occurred in Event-Driven (China TCM, GA Pack, HEC CJ Pharma, CPMC, Alps Logistics, Infocom, Hollysys, Adbri, Qantm...

Logo
347 Views
Share
x